Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Plos Neglected Tropical Diseases
|
June 4, 2020
Characterization and applications of a Crimean-Congo hemorrhagic fever virus nucleoprotein-specific Affimer: Inhibitory effects in viral replication and development of colorimetric diagnostic tests
Beatriz Álvarez-Rodríguez, Christian Tiede, Alexis C R Hoste, et al.
The Journal of Biological Chemistry
|
October 7, 2023
"Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation
Barnaby W R Roper, Christian Tiede, Izma Abdul-Zani, et al.
RSC Advances
|
March 29, 2016
Trivalent Gd-DOTA reagents for modification of proteins
Martin J Fisher, Daniel J Williamson, George M Burslem, et al.
Chembiochem : a European Journal of Chemical Biology
|
September 22, 2020
Selective Affimers Recognise the BCL-2 Family Proteins BCL-x<sub>L</sub> and MCL-1 through Noncanonical Structural Motifs*
Jennifer A Miles, Fruzsina Hobor, Chi H Trinh, et al.
Protein Engineering, Design & Selection : PEDS
|
May 28, 2011
Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant
Lukas Kurt Josef Stadler, Toni Hoffmann, Darren Charles Tomlinson, et al.
Blood
|
December 15, 2018
Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications
Katherine J Kearney, Nikoletta Pechlivani, Rhodri King, et al.
Iscience
|
August 6, 2024
Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particles
Sophie E Roberts, Heather L Martin, Danah Al-Qallaf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2017
Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action
James I Robinson, Euan W Baxter, Robin L Owen, et al.
Cell Reports
|
September 30, 2023
Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition
Heather L Martin, Amy L Turner, Julie Higgins, et al.
Blood Advances
|
June 5, 2024
Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer
Rui-Gang Xu, Christian Tiede, Antonio N Calabrese, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Plos Neglected Tropical Diseases
|
June 4, 2020
Characterization and applications of a Crimean-Congo hemorrhagic fever virus nucleoprotein-specific Affimer: Inhibitory effects in viral replication and development of colorimetric diagnostic tests
Beatriz Álvarez-Rodríguez, Christian Tiede, Alexis C R Hoste, et al.
The Journal of Biological Chemistry
|
October 7, 2023
"Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation
Barnaby W R Roper, Christian Tiede, Izma Abdul-Zani, et al.
RSC Advances
|
March 29, 2016
Trivalent Gd-DOTA reagents for modification of proteins
Martin J Fisher, Daniel J Williamson, George M Burslem, et al.
Chembiochem : a European Journal of Chemical Biology
|
September 22, 2020
Selective Affimers Recognise the BCL-2 Family Proteins BCL-x<sub>L</sub> and MCL-1 through Noncanonical Structural Motifs*
Jennifer A Miles, Fruzsina Hobor, Chi H Trinh, et al.
Protein Engineering, Design & Selection : PEDS
|
May 28, 2011
Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant
Lukas Kurt Josef Stadler, Toni Hoffmann, Darren Charles Tomlinson, et al.
Blood
|
December 15, 2018
Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications
Katherine J Kearney, Nikoletta Pechlivani, Rhodri King, et al.
Iscience
|
August 6, 2024
Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particles
Sophie E Roberts, Heather L Martin, Danah Al-Qallaf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2017
Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action
James I Robinson, Euan W Baxter, Robin L Owen, et al.
Cell Reports
|
September 30, 2023
Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition
Heather L Martin, Amy L Turner, Julie Higgins, et al.
Blood Advances
|
June 5, 2024
Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer
Rui-Gang Xu, Christian Tiede, Antonio N Calabrese, et al.
Page
of 5